nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—Wound dehiscence—Carmustine—malignant glioma	0.101	0.135	CcSEcCtD
Fluocinolone Acetonide—Wound—Carmustine—malignant glioma	0.08	0.107	CcSEcCtD
Fluocinolone Acetonide—Condition aggravated—Temozolomide—malignant glioma	0.0614	0.0822	CcSEcCtD
Fluocinolone Acetonide—Conjunctival oedema—Carmustine—malignant glioma	0.0418	0.056	CcSEcCtD
Fluocinolone Acetonide—Retinal haemorrhage—Carmustine—malignant glioma	0.0356	0.0477	CcSEcCtD
Fluocinolone Acetonide—Impaired healing—Carmustine—malignant glioma	0.0268	0.0359	CcSEcCtD
Fluocinolone Acetonide—Skin hyperpigmentation—Carmustine—malignant glioma	0.0195	0.0261	CcSEcCtD
Fluocinolone Acetonide—Visual acuity reduced—Temozolomide—malignant glioma	0.0189	0.0252	CcSEcCtD
Fluocinolone Acetonide—Abscess—Carmustine—malignant glioma	0.0147	0.0196	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Temozolomide—malignant glioma	0.0144	0.0193	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Temozolomide—malignant glioma	0.0124	0.0166	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Temozolomide—malignant glioma	0.0122	0.0163	CcSEcCtD
Fluocinolone Acetonide—Neck pain—Carmustine—malignant glioma	0.0117	0.0157	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Temozolomide—malignant glioma	0.0104	0.0139	CcSEcCtD
Fluocinolone Acetonide—Ear pain—Temozolomide—malignant glioma	0.00954	0.0128	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Carmustine—malignant glioma	0.00933	0.0125	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Temozolomide—malignant glioma	0.00918	0.0123	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Temozolomide—malignant glioma	0.00902	0.0121	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Carmustine—malignant glioma	0.00842	0.0113	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Temozolomide—malignant glioma	0.00814	0.0109	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00654	0.00875	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Temozolomide—malignant glioma	0.00627	0.0084	CcSEcCtD
Fluocinolone Acetonide—Infestation—Temozolomide—malignant glioma	0.00627	0.0084	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Temozolomide—malignant glioma	0.00589	0.00788	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Carmustine—malignant glioma	0.00573	0.00767	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Carmustine—malignant glioma	0.00562	0.00752	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Temozolomide—malignant glioma	0.00553	0.00741	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Carmustine—malignant glioma	0.00545	0.00729	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Temozolomide—malignant glioma	0.00543	0.00726	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Temozolomide—malignant glioma	0.00526	0.00704	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Carmustine—malignant glioma	0.00515	0.00689	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Carmustine—malignant glioma	0.00511	0.00683	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Temozolomide—malignant glioma	0.00508	0.00679	CcSEcCtD
Fluocinolone Acetonide—Erythema—Carmustine—malignant glioma	0.00507	0.00679	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Carmustine—malignant glioma	0.00507	0.00679	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Temozolomide—malignant glioma	0.00498	0.00666	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Temozolomide—malignant glioma	0.00493	0.0066	CcSEcCtD
Fluocinolone Acetonide—Back pain—Carmustine—malignant glioma	0.00491	0.00657	CcSEcCtD
Fluocinolone Acetonide—Erythema—Temozolomide—malignant glioma	0.0049	0.00656	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Temozolomide—malignant glioma	0.0049	0.00656	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Temozolomide—malignant glioma	0.0048	0.00643	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Carmustine—malignant glioma	0.00478	0.0064	CcSEcCtD
Fluocinolone Acetonide—Back pain—Temozolomide—malignant glioma	0.00474	0.00635	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Temozolomide—malignant glioma	0.00462	0.00618	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Temozolomide—malignant glioma	0.0044	0.0059	CcSEcCtD
Fluocinolone Acetonide—Cough—Temozolomide—malignant glioma	0.00428	0.00573	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Temozolomide—malignant glioma	0.00417	0.00559	CcSEcCtD
Fluocinolone Acetonide—Oedema—Carmustine—malignant glioma	0.00414	0.00554	CcSEcCtD
Fluocinolone Acetonide—Infection—Carmustine—malignant glioma	0.00411	0.00551	CcSEcCtD
Fluocinolone Acetonide—Oedema—Temozolomide—malignant glioma	0.004	0.00536	CcSEcCtD
Fluocinolone Acetonide—Infection—Temozolomide—malignant glioma	0.00397	0.00532	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Temozolomide—malignant glioma	0.00392	0.00525	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00377	0.00505	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00365	0.00488	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Carmustine—malignant glioma	0.00357	0.00478	CcSEcCtD
Fluocinolone Acetonide—Pain—Carmustine—malignant glioma	0.00354	0.00474	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00345	0.00462	CcSEcCtD
Fluocinolone Acetonide—Pain—Temozolomide—malignant glioma	0.00342	0.00458	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Carmustine—malignant glioma	0.00327	0.00438	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Temozolomide—malignant glioma	0.00316	0.00423	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Carmustine—malignant glioma	0.00305	0.00408	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Temozolomide—malignant glioma	0.00295	0.00395	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Carmustine—malignant glioma	0.00283	0.00379	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Temozolomide—malignant glioma	0.00283	0.00379	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Carmustine—malignant glioma	0.00274	0.00366	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Temozolomide—malignant glioma	0.00274	0.00366	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Temozolomide—malignant glioma	0.00265	0.00354	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Carmustine—malignant glioma	0.00263	0.00352	CcSEcCtD
Fluocinolone Acetonide—Rash—Carmustine—malignant glioma	0.00261	0.00349	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Carmustine—malignant glioma	0.00261	0.00349	CcSEcCtD
Fluocinolone Acetonide—Headache—Carmustine—malignant glioma	0.00259	0.00347	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Temozolomide—malignant glioma	0.00254	0.00341	CcSEcCtD
Fluocinolone Acetonide—Rash—Temozolomide—malignant glioma	0.00252	0.00338	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Temozolomide—malignant glioma	0.00252	0.00337	CcSEcCtD
Fluocinolone Acetonide—Headache—Temozolomide—malignant glioma	0.00251	0.00336	CcSEcCtD
Fluocinolone Acetonide—Nausea—Carmustine—malignant glioma	0.00246	0.00329	CcSEcCtD
Fluocinolone Acetonide—Nausea—Temozolomide—malignant glioma	0.00238	0.00318	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—BCHE—malignant glioma	0.00131	0.379	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ANGPT2—malignant glioma	0.00101	0.00406	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.00101	0.00403	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—BRAF—malignant glioma	0.000993	0.00398	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PIK3CG—malignant glioma	0.000976	0.00391	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—NCOR1—malignant glioma	0.000976	0.00391	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.000973	0.0039	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000971	0.00389	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CDKN2A—malignant glioma	0.000965	0.00387	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—EGFR—malignant glioma	0.000948	0.0038	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—IFNG—malignant glioma	0.000941	0.00377	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.000923	0.0037	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—HIST1H3B—malignant glioma	0.000877	0.00351	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—PIK3CA—malignant glioma	0.000876	0.00351	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CXCL8—malignant glioma	0.000875	0.00351	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MYB—malignant glioma	0.000869	0.00348	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000867	0.00348	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000867	0.00347	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LATS2—malignant glioma	0.000862	0.00346	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PIK3CD—malignant glioma	0.000858	0.00344	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000848	0.0034	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000839	0.00336	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—IL2—malignant glioma	0.000837	0.00335	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—malignant glioma	0.000829	0.00332	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—RAF1—malignant glioma	0.000829	0.00332	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—malignant glioma	0.000825	0.00331	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—HIF1A—malignant glioma	0.000822	0.0033	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—PIK3CB—malignant glioma	0.00081	0.00325	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—MMP9—malignant glioma	0.000792	0.00317	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—PTEN—malignant glioma	0.000787	0.00316	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000777	0.00312	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000776	0.00311	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—malignant glioma	0.000771	0.00309	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—CYP2B6—malignant glioma	0.000763	0.221	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000753	0.00302	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PIK3CB—malignant glioma	0.000748	0.003	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000744	0.00298	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—malignant glioma	0.000737	0.00295	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—malignant glioma	0.000716	0.00287	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000711	0.00285	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—F2—malignant glioma	0.0007	0.00281	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.0007	0.00281	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—PTEN—malignant glioma	0.0007	0.0028	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—PPARG—malignant glioma	0.000699	0.0028	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—AKT1—malignant glioma	0.000697	0.0028	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—COX8A—malignant glioma	0.000697	0.00279	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—H3F3A—malignant glioma	0.000677	0.00271	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—AKT1—malignant glioma	0.000672	0.00269	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.00067	0.00268	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000662	0.00265	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000658	0.00264	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—MYC—malignant glioma	0.000654	0.00262	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LATS1—malignant glioma	0.000653	0.00262	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PTEN—malignant glioma	0.000646	0.00259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000634	0.00254	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—STAT3—malignant glioma	0.000626	0.00251	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000623	0.0025	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000613	0.00246	CbGpPWpGaD
Fluocinolone Acetonide—Triamcinolone—PTGS2—malignant glioma	0.000603	0.174	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000602	0.00241	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000593	0.00238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ASMT—malignant glioma	0.000592	0.00237	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000591	0.00237	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000589	0.00236	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000584	0.00234	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.000582	0.00233	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MYC—malignant glioma	0.000581	0.00233	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000579	0.00232	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000571	0.00229	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—KNG1—malignant glioma	0.000558	0.00224	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—BCAN—malignant glioma	0.000557	0.00223	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IFNA2—malignant glioma	0.000547	0.00219	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TP53—malignant glioma	0.000537	0.00215	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—KRAS—malignant glioma	0.000537	0.00215	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.00053	0.00213	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.000526	0.00211	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SOD1—malignant glioma	0.000518	0.00208	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCR4—malignant glioma	0.000518	0.00208	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000513	0.00206	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000498	0.002	CbGpPWpGaD
Fluocinolone Acetonide—Betamethasone—PTGS2—malignant glioma	0.000494	0.143	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—malignant glioma	0.000494	0.00198	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NOTCH3—malignant glioma	0.000487	0.00195	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PTK2—malignant glioma	0.000476	0.00191	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—malignant glioma	0.000473	0.0019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.000471	0.00189	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000461	0.00185	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PIK3CA—malignant glioma	0.000456	0.00183	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.00045	0.0018	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—IDH2—malignant glioma	0.000449	0.0018	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000442	0.00177	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MDK—malignant glioma	0.000441	0.00177	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000441	0.00177	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000437	0.00175	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—STAT3—malignant glioma	0.000429	0.00172	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000423	0.0017	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2B6—malignant glioma	0.000422	0.00169	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DTX1—malignant glioma	0.000421	0.00169	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000414	0.00166	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000405	0.00162	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.000404	0.00162	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	0.000401	0.00161	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PDGFB—malignant glioma	0.0004	0.0016	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—malignant glioma	0.0004	0.0016	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—IDH1—malignant glioma	0.000386	0.00155	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000386	0.00155	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCR3—malignant glioma	0.000385	0.00154	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000383	0.00153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CAV1—malignant glioma	0.000379	0.00152	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000376	0.00151	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000374	0.0015	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SPHK1—malignant glioma	0.000373	0.0015	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TNF—malignant glioma	0.000371	0.00149	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2C18—malignant glioma	0.000366	0.00147	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—F2—malignant glioma	0.000361	0.00145	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—FN1—malignant glioma	0.000361	0.00145	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NCOR1—malignant glioma	0.000356	0.00143	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—BDKRB2—malignant glioma	0.000352	0.00141	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000352	0.00141	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CG—malignant glioma	0.000345	0.00138	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000345	0.00138	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—EGF—malignant glioma	0.000341	0.00137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.00034	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PTPN11—malignant glioma	0.000339	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SUFU—malignant glioma	0.000335	0.00134	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—DNMT3B—malignant glioma	0.000333	0.00133	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HEY2—malignant glioma	0.00033	0.00132	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HIST1H3B—malignant glioma	0.000323	0.0013	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GFAP—malignant glioma	0.000323	0.00129	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000321	0.00129	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KNG1—malignant glioma	0.00032	0.00128	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT2—malignant glioma	0.000316	0.00127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000314	0.00126	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	0.000313	0.00125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SPHK1—malignant glioma	0.000312	0.00125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HEY1—malignant glioma	0.000306	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR4—malignant glioma	0.000306	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CD—malignant glioma	0.000303	0.00122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000303	0.00122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HIST1H3B—malignant glioma	0.000297	0.00119	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTT1—malignant glioma	0.000296	0.00119	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000287	0.00115	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—malignant glioma	0.000287	0.0831	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MMP3—malignant glioma	0.000284	0.00114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS1—malignant glioma	0.000277	0.00111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000276	0.00111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JAG2—malignant glioma	0.000271	0.00109	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—RAF1—malignant glioma	0.000271	0.00109	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000271	0.00108	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CB—malignant glioma	0.000265	0.00106	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—BCHE—malignant glioma	0.000258	0.00103	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—malignant glioma	0.000256	0.00102	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARG—malignant glioma	0.000255	0.00102	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC5A5—malignant glioma	0.000255	0.00102	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—H3F3A—malignant glioma	0.00025	0.001	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IL2—malignant glioma	0.000243	0.000974	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000241	0.000965	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000239	0.000956	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NOTCH3—malignant glioma	0.000235	0.00094	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—H3F3A—malignant glioma	0.00023	0.00092	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCR3—malignant glioma	0.000227	0.000912	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—YWHAE—malignant glioma	0.000221	0.000887	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NTRK2—malignant glioma	0.000221	0.000887	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FLT1—malignant glioma	0.00022	0.000883	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DUSP6—malignant glioma	0.000219	0.000879	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JAG1—malignant glioma	0.000216	0.000868	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOTCH3—malignant glioma	0.000216	0.000864	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FBXW7—malignant glioma	0.000212	0.00085	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NOTCH2—malignant glioma	0.00021	0.000843	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000208	0.000834	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BDKRB2—malignant glioma	0.000208	0.000834	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—F2—malignant glioma	0.000207	0.00083	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—malignant glioma	0.000206	0.000828	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTP1—malignant glioma	0.000205	0.000822	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CAT—malignant glioma	0.0002	0.0008	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CG—malignant glioma	0.000198	0.000794	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PTPN11—malignant glioma	0.000195	0.00078	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOTCH2—malignant glioma	0.000193	0.000775	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KNG1—malignant glioma	0.000189	0.000758	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCOR1—malignant glioma	0.000188	0.000756	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT2—malignant glioma	0.000181	0.000727	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CDKN2B—malignant glioma	0.000181	0.000725	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NTRK1—malignant glioma	0.00018	0.000723	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—KRAS—malignant glioma	0.000176	0.000704	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CD—malignant glioma	0.000174	0.000698	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NCOR1—malignant glioma	0.000172	0.000688	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP3—malignant glioma	0.000168	0.000672	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN2B—malignant glioma	0.000166	0.000666	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTK2—malignant glioma	0.000161	0.000647	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CA—malignant glioma	0.000161	0.000646	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HES1—malignant glioma	0.000159	0.000635	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NCOR1—malignant glioma	0.000158	0.000632	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—malignant glioma	0.000156	0.000625	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—RAF1—malignant glioma	0.000155	0.000623	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CAV1—malignant glioma	0.000154	0.000616	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CB—malignant glioma	0.000152	0.000609	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDGFRA—malignant glioma	0.000151	0.000605	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000147	0.000588	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SPP1—malignant glioma	0.000147	0.000587	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL8—malignant glioma	0.000146	0.000585	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—MYC—malignant glioma	0.000146	0.000583	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CG—malignant glioma	0.00014	0.000561	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL2—malignant glioma	0.000139	0.000559	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TERT—malignant glioma	0.000139	0.000557	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDGFB—malignant glioma	0.000136	0.000543	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARG—malignant glioma	0.000135	0.000541	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGFR1—malignant glioma	0.000135	0.000541	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HIF1A—malignant glioma	0.000133	0.000533	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—malignant glioma	0.000132	0.000528	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NOTCH1—malignant glioma	0.00013	0.000522	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CAV1—malignant glioma	0.000128	0.000515	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KDR—malignant glioma	0.000127	0.000509	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CD—malignant glioma	0.000123	0.000493	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARG—malignant glioma	0.000123	0.000493	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—F2—malignant glioma	0.000122	0.00049	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FN1—malignant glioma	0.000122	0.00049	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BAD—malignant glioma	0.000121	0.000484	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOTCH1—malignant glioma	0.00012	0.00048	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CD80—malignant glioma	0.000117	0.00047	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APC—malignant glioma	0.000117	0.000469	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CG—malignant glioma	0.000117	0.000469	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGF—malignant glioma	0.000116	0.000464	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTPN11—malignant glioma	0.000115	0.000461	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BRAF—malignant glioma	0.00011	0.000441	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CB—malignant glioma	0.000107	0.00043	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT2—malignant glioma	0.000107	0.000429	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EGFR—malignant glioma	0.000107	0.000427	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—malignant glioma	0.000106	0.000426	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CD—malignant glioma	0.000103	0.000412	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KRAS—malignant glioma	0.000101	0.000404	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF2—malignant glioma	9.85e-05	0.000395	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTEN—malignant glioma	9.27e-05	0.000371	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CA—malignant glioma	9.25e-05	0.000371	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MDM2—malignant glioma	9.22e-05	0.000369	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RAF1—malignant glioma	9.19e-05	0.000368	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB2—malignant glioma	9.09e-05	0.000364	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CB—malignant glioma	8.97e-05	0.000359	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL8—malignant glioma	8.62e-05	0.000345	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASP3—malignant glioma	8.25e-05	0.000331	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL2—malignant glioma	8.24e-05	0.00033	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP9—malignant glioma	7.79e-05	0.000312	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTEN—malignant glioma	7.75e-05	0.000311	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—malignant glioma	7.56e-05	0.000303	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MYC—malignant glioma	7.01e-05	0.000281	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—malignant glioma	7e-05	0.000281	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT3—malignant glioma	6.93e-05	0.000278	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CA—malignant glioma	6.54e-05	0.000262	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MYC—malignant glioma	6.44e-05	0.000258	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGFR—malignant glioma	6.3e-05	0.000252	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KRAS—malignant glioma	5.95e-05	0.000239	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CA—malignant glioma	5.47e-05	0.000219	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—malignant glioma	5.34e-05	0.000214	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—malignant glioma	5.29e-05	0.000212	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—malignant glioma	4.86e-05	0.000195	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—malignant glioma	4.47e-05	0.000179	CbGpPWpGaD
